3/18
01:31 pm
syre
Rating for SYRE
Low
Report
Rating for SYRE
3/16
12:47 pm
syre
Spyre Therapeutics (SYRE) had its "buy" rating reaffirmed by BTIG Research. They now have a $70.00 price target on the stock.
Low
Report
Spyre Therapeutics (SYRE) had its "buy" rating reaffirmed by BTIG Research. They now have a $70.00 price target on the stock.
3/16
12:22 pm
syre
Rating for SYRE
Low
Report
Rating for SYRE
2/24
06:48 am
syre
Spyre Therapeutics (NASDAQ:SYRE) was upgraded by analysts at Leerink Partners to a "strong-buy" rating.
Low
Report
Spyre Therapeutics (NASDAQ:SYRE) was upgraded by analysts at Leerink Partners to a "strong-buy" rating.
2/20
12:59 pm
syre
Rating for SYRE
Medium
Report
Rating for SYRE
2/20
12:59 pm
syre
Rating for SYRE
Medium
Report
Rating for SYRE
2/20
12:22 pm
syre
Spyre Therapeutics (NASDAQ:SYRE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $70.00 price target on the stock.
Medium
Report
Spyre Therapeutics (NASDAQ:SYRE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $70.00 price target on the stock.
2/20
12:00 pm
syre
Rating for SYRE
Medium
Report
Rating for SYRE
1/16
10:40 am
syre
Spyre Therapeutics (NASDAQ:SYRE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $70.00 price target on the stock.
Low
Report
Spyre Therapeutics (NASDAQ:SYRE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $70.00 price target on the stock.
1/16
10:24 am
syre
Rating for SYRE
Low
Report
Rating for SYRE